MedTrace Logo

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

NCT07182136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-19

No results posted yet for this study

Summary

We will use simple summaries, educational handouts, and discussions with doctors and nurses to explain this study. The study looks at patients with early-stage pancreatic cancer who undergo pancreaticoduodenectomy (Whipple surgery). We found that some patients develop fatty liver (non-alcoholic fatty liver disease, NAFLD) within six months after surgery, which can affect nutrition, blood sugar control, and long-term survival.

To help patients and families understand, we will:

1. Provide clear written information sheets about the purpose of the study and its findings.
2. Use diagrams or plain-language explanations of terms like "pancreatic exocrine function" and "fatty liver."
3. Share results with healthcare providers so they can guide patients in nutrition, enzyme replacement, diabetes monitoring, and follow-up care.
4. Offer contact information for the research team to answer questions.

Conditions

  • Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy

Interventions

PROCEDURE

Pancreaticoduodenectomy

Retrospective study evaluating postoperative NAFLD and metabolic outcomes in patients with stage I-II pancreatic cancer after PD.

Sponsors & Collaborators

  • Wei-Hsun Lu

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2023-03-31
Completion
2025-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07182136 on ClinicalTrials.gov